The management of choledochal cysts in the newborn

C A Burnweit1, G A Birken, K Heiss

  • 1Miami Children's Hospital, Miami, FL, USA.

Insights

Early surgical intervention for choledochal cysts in newborns, even asymptomatic cases, is safe and effective. This management strategy prevents future serious complications, ensuring normal bilirubin levels post-operation.

Area of Science:

  • Pediatric Surgery
  • Gastroenterology
  • Neonatal Care

Background:

  • Choledochal cysts are increasingly diagnosed prenatally via ultrasound (US).
  • Limited literature exists on managing newborns with choledochal cysts, many presenting asymptomatically.
  • This study addresses the diagnosis, treatment, and outcomes of infants with choledochal cysts.

Purpose of the Study:

  • To detail the management of newborns diagnosed with choledochal cysts.
  • To evaluate the safety and efficacy of early surgical intervention.
  • To report outcomes and long-term follow-up of treated infants.

Main Methods:

  • Retrospective review of six infants (4 female, 2 male) with choledochal cysts.
  • Diagnosis confirmed via antenatal or postnatal ultrasound and preoperative studies.
  • Surgical management involved cyst resection with Roux-en-Y choledochojejunostomy or a choledochoduodenal conduit.

Main Results:

  • Five infants diagnosed via antenatal US; one with intermittent vomiting.
  • Alonso-Lej type I cysts identified in all cases via cholangiography.
  • No intraoperative or early postoperative complications; average hospital stay was 8 days.

Conclusions:

  • Early surgical treatment of choledochal cysts in infancy is safe and effective.
  • Proactive management can prevent severe long-term complications.
  • All patients achieved normal bilirubin levels with an average follow-up of 35 months.

Related Concept Videos

Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Peptic Ulcer Disease V: Surgical Management and Nursing Care01:25

Peptic Ulcer Disease V: Surgical Management and Nursing Care

Surgical management and nursing care are crucial in treating Peptic Ulcer Disease (PUD). Here is an organized and enhanced overview of the surgical interventions and the associated nursing care for PUD:
Surgical Interventions for Peptic Ulcer Disease
Cholecystitis01:20

Cholecystitis

Cholecystitis is inflammation of the gallbladder, most commonly caused by obstruction of the cystic duct. This blockage prevents bile from draining, leading to gallbladder distension, inflammation, and potentially serious complications. This condition may present acutely or chronically and can happen with or without gallstones.EtiologyAbout 95% of cholecystitis cases are calculous, caused by gallstones blocking the cystic duct, leading to bile accumulation and inflammation of the gallbladder...
Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...